Skip to main content
Top
Published in: International Journal of Hematology 6/2016

01-12-2016 | Original Article

Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions

Authors: Yasunori Matsunari, Mitsuhiko Sugimoto, Masaaki Doi, Hideto Matsui, Masahiko Kawaguchi

Published in: International Journal of Hematology | Issue 6/2016

Login to get access

Abstract

Von Willebrand factor (VWF) plays an important role in mediating platelet adhesion and aggregation under high shear rate conditions. Such platelet aggregates are strengthened by fibrin-network formation triggered by tissue factor (TF). However, little is known about the role of TF in VWF-dependent thrombus formation under blood flow conditions. We evaluated TF in thrombus formation on immobilized VWF under whole blood flow conditions in an in vitro perfusion chamber system. Surface-immobilized TF amplified intra-thrombus fibrin generation significantly under both low and high shear flow conditions, while TF in sample blood showed no appreciable effects. Furthermore, immobilized TF enhanced VWF-dependent platelet adhesion and aggregation significantly under high shear rates. Neutrophil cathepsin G and elastase increased significantly intra-thrombus fibrin deposition on immobilized VWF–TF complex, suggesting the involvement of leukocyte inflammatory responses in VWF/TF-dependent mural thrombogenesis under these flow conditions. These results reveal a functional link between VWF and TF under whole blood flow conditions, in which surface-immobilized TF and VWF mutually contribute to mural thrombus formation, which is essential for normal hemostasis. By contrast, TF circulating in blood may be involved in systemic hypercoagulability, as seen in sepsis caused by severe microbial infection, in which neutrophil inflammatory responses may be active.
Literature
1.
go back to reference Sixma JJ, Waster J. The hemostatic plug. Semin Hematol. 1977;14:265–99.PubMed Sixma JJ, Waster J. The hemostatic plug. Semin Hematol. 1977;14:265–99.PubMed
3.
go back to reference Stoll G, Kleinschnitz C, Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood. 2008;112:3555–62.CrossRefPubMed Stoll G, Kleinschnitz C, Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood. 2008;112:3555–62.CrossRefPubMed
4.
go back to reference Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992;326:242–50.CrossRefPubMed Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992;326:242–50.CrossRefPubMed
5.
go back to reference Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992;326:310–8.CrossRefPubMed Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992;326:310–8.CrossRefPubMed
6.
go back to reference Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996;88:1525–41.PubMed Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996;88:1525–41.PubMed
7.
go back to reference Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289–97.CrossRefPubMed Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289–97.CrossRefPubMed
8.
go back to reference Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657–66.CrossRefPubMed Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657–66.CrossRefPubMed
9.
go back to reference Heemskerk JW, Kuijpers MJ, Munnix IC, Siljander PR. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med. 2005;15(3):86–92.CrossRefPubMed Heemskerk JW, Kuijpers MJ, Munnix IC, Siljander PR. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med. 2005;15(3):86–92.CrossRefPubMed
10.
go back to reference Fogelson AL, Tania N. Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb. 2005;34:91–108.CrossRefPubMed Fogelson AL, Tania N. Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb. 2005;34:91–108.CrossRefPubMed
11.
go back to reference Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2006;26:1729–37.CrossRefPubMed Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2006;26:1729–37.CrossRefPubMed
12.
go back to reference Mizuno T, Sugimoto M, Matsui H, Hamada M, Shida Y, Yoshioka A. Visual evaluation of blood coagulation during mural thrombogenesis under high shear flow. Thromb Res. 2008;121:855–64.CrossRefPubMed Mizuno T, Sugimoto M, Matsui H, Hamada M, Shida Y, Yoshioka A. Visual evaluation of blood coagulation during mural thrombogenesis under high shear flow. Thromb Res. 2008;121:855–64.CrossRefPubMed
13.
go back to reference Shen F, Kastrup CJ, Liu Y, Ismagilov RF. Threshold response of initiation of blood coagulation by tissue factor in patterned microfluidic capillaries is controlled by shear rate. Arterioscler Thromb Vasc Biol. 2008;28:2035–41.CrossRefPubMed Shen F, Kastrup CJ, Liu Y, Ismagilov RF. Threshold response of initiation of blood coagulation by tissue factor in patterned microfluidic capillaries is controlled by shear rate. Arterioscler Thromb Vasc Biol. 2008;28:2035–41.CrossRefPubMed
14.
go back to reference Neeves KB, McCarty OJT, Reininger AJ, Sugimoto M, King MR. Flow-dependent thrombin and fibrin generation in vitro: opportunities for standardization: communication from SSC of the ISTH. J Thromb Haemost. 2014;12:418–20.CrossRefPubMed Neeves KB, McCarty OJT, Reininger AJ, Sugimoto M, King MR. Flow-dependent thrombin and fibrin generation in vitro: opportunities for standardization: communication from SSC of the ISTH. J Thromb Haemost. 2014;12:418–20.CrossRefPubMed
15.
go back to reference Gemmell CH, Turitto VT, Nemerson Y. Flow as a regulator of the activation of factor-X by tissue factor. Blood. 1988;72:1404–6.PubMed Gemmell CH, Turitto VT, Nemerson Y. Flow as a regulator of the activation of factor-X by tissue factor. Blood. 1988;72:1404–6.PubMed
16.
go back to reference Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood. 2008;111:3507–13.CrossRefPubMedPubMedCentral Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood. 2008;111:3507–13.CrossRefPubMedPubMedCentral
17.
go back to reference Morrissey JH. Tissue Factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol. 2004;79:103–8.CrossRefPubMed Morrissey JH. Tissue Factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol. 2004;79:103–8.CrossRefPubMed
18.
go back to reference Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost. 2003;1:1335–42.CrossRefPubMed Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost. 2003;1:1335–42.CrossRefPubMed
19.
go back to reference Doi M, Sugimoto M, Matsui H, Matsunari Y, Shima M. Coagulation potential of immobilized factor VIII in flow-dependent fibrin generation on platelet surfaces. Thromb Haemost. 2013;110:316–22.CrossRefPubMed Doi M, Sugimoto M, Matsui H, Matsunari Y, Shima M. Coagulation potential of immobilized factor VIII in flow-dependent fibrin generation on platelet surfaces. Thromb Haemost. 2013;110:316–22.CrossRefPubMed
20.
go back to reference Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem. 1991;266:18172–8.PubMed Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem. 1991;266:18172–8.PubMed
21.
go back to reference Hamada M, Sugimoto M, Matsui H, Mizuno T, Shida Y, Doi M, et al. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions. Thromb Haemost. 2011;105:313–20.CrossRefPubMed Hamada M, Sugimoto M, Matsui H, Mizuno T, Shida Y, Doi M, et al. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions. Thromb Haemost. 2011;105:313–20.CrossRefPubMed
22.
go back to reference Kuwahara M, Sugimoto M, Tsuji S, Miyata S, Yoshioka A. Cytosolic calcium changes in a process of platelet adhesion and cohesion on a von Willebrand factor-coated surface under flow conditions. Blood. 1999;94:1149–55.PubMed Kuwahara M, Sugimoto M, Tsuji S, Miyata S, Yoshioka A. Cytosolic calcium changes in a process of platelet adhesion and cohesion on a von Willebrand factor-coated surface under flow conditions. Blood. 1999;94:1149–55.PubMed
23.
go back to reference Matsui H, Sugimoto M, Mizuno T, Tsuji S, Miyata S, Matsuda M, et al. Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow. Blood. 2002;100:3604–10.CrossRefPubMed Matsui H, Sugimoto M, Mizuno T, Tsuji S, Miyata S, Matsuda M, et al. Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow. Blood. 2002;100:3604–10.CrossRefPubMed
24.
go back to reference Sugimoto M, Matsui H, Mizuno T, Tsuji S, Miyata S, Matsumoto M, et al. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood. 2003;101:915–20.CrossRefPubMed Sugimoto M, Matsui H, Mizuno T, Tsuji S, Miyata S, Matsumoto M, et al. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood. 2003;101:915–20.CrossRefPubMed
25.
go back to reference Shida Y, Nishio K, Sugimoto M, Mizuno T, Hamada M, Kato S, et al. Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions. Blood. 2008;111:1295–8.CrossRefPubMed Shida Y, Nishio K, Sugimoto M, Mizuno T, Hamada M, Kato S, et al. Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions. Blood. 2008;111:1295–8.CrossRefPubMed
26.
go back to reference Tsuji S, Sugimoto M, Miyata S, Kuwahara M, Kinoshita S, Yoshioka A. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood. 1999;94:968–75.PubMed Tsuji S, Sugimoto M, Miyata S, Kuwahara M, Kinoshita S, Yoshioka A. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood. 1999;94:968–75.PubMed
27.
go back to reference Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395–424.CrossRefPubMed Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395–424.CrossRefPubMed
28.
30.
go back to reference Giessen PLA, Rauch U, Bohmann B, Kling D, Roqué M, Fallon JT, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96:2311–5.CrossRef Giessen PLA, Rauch U, Bohmann B, Kling D, Roqué M, Fallon JT, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96:2311–5.CrossRef
31.
go back to reference Balasubramanian V, Vele O, Nemerson Y. Local shear conditions and platelet aggregates regulate the incorporation and activity of circulating tissue factor in ex vivo thrombi. Thromb Haemost. 2002;88:822–6.PubMed Balasubramanian V, Vele O, Nemerson Y. Local shear conditions and platelet aggregates regulate the incorporation and activity of circulating tissue factor in ex vivo thrombi. Thromb Haemost. 2002;88:822–6.PubMed
32.
go back to reference Ramacciotti E, Hawley AE, Farris DM, Ballard NE, Wrobleski SK, Myers DD Jr, et al. Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost. 2009;101:748–54.PubMedPubMedCentral Ramacciotti E, Hawley AE, Farris DM, Ballard NE, Wrobleski SK, Myers DD Jr, et al. Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost. 2009;101:748–54.PubMedPubMedCentral
33.
go back to reference Ikezoe T. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin. Int J Hematol. 2014;100:27–37.CrossRefPubMed Ikezoe T. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin. Int J Hematol. 2014;100:27–37.CrossRefPubMed
34.
go back to reference Orvim U, Roald HE, Stephens RW, Roos N, Sakariassen KS. Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions. Arterioscler Thromb Vasc Biol. 1994;14:1976–83.CrossRef Orvim U, Roald HE, Stephens RW, Roos N, Sakariassen KS. Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions. Arterioscler Thromb Vasc Biol. 1994;14:1976–83.CrossRef
35.
go back to reference De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem. 1994;269:6478–84.PubMed De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem. 1994;269:6478–84.PubMed
36.
go back to reference Kahn ML. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;6:879–87.CrossRef Kahn ML. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;6:879–87.CrossRef
37.
go back to reference Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol. 2002;22:1381–9.CrossRefPubMed Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol. 2002;22:1381–9.CrossRefPubMed
38.
go back to reference Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003;197:1585–98.CrossRefPubMedPubMedCentral Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003;197:1585–98.CrossRefPubMedPubMedCentral
39.
go back to reference Steppich BA, Seitz I, Busch G, Stein A, Ott I. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases. Thromb Haemost. 2008;100:1068–75.PubMed Steppich BA, Seitz I, Busch G, Stein A, Ott I. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases. Thromb Haemost. 2008;100:1068–75.PubMed
40.
go back to reference Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010;16:887–96.CrossRefPubMed Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010;16:887–96.CrossRefPubMed
41.
go back to reference Goel MS, Diamond SL. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets. J Biol Chem. 2003;278:9458–63.CrossRefPubMed Goel MS, Diamond SL. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets. J Biol Chem. 2003;278:9458–63.CrossRefPubMed
42.
go back to reference Doi M, Matsui H, Takeda H, Saito Y, Takeda M, Matsunari Y, et al. ADAMTS13 safeguards the myocardium in a mouse model of myocardial infarction. Thromb Haemost. 2012;108:1236–8.CrossRefPubMed Doi M, Matsui H, Takeda H, Saito Y, Takeda M, Matsunari Y, et al. ADAMTS13 safeguards the myocardium in a mouse model of myocardial infarction. Thromb Haemost. 2012;108:1236–8.CrossRefPubMed
43.
go back to reference De Meyer SF, Savchenco AS, Haas MS, Schatzberg D, Carroll MC, Schiviz A, et al. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood. 2012;120:5217–23.CrossRefPubMedPubMedCentral De Meyer SF, Savchenco AS, Haas MS, Schatzberg D, Carroll MC, Schiviz A, et al. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood. 2012;120:5217–23.CrossRefPubMedPubMedCentral
44.
go back to reference Kasuda S, Matsui H, Ono S, Matsunari Y, Nishio K, Shima M, et al. Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture. Haematologica. 2016;101:e52–4.CrossRefPubMedPubMedCentral Kasuda S, Matsui H, Ono S, Matsunari Y, Nishio K, Shima M, et al. Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture. Haematologica. 2016;101:e52–4.CrossRefPubMedPubMedCentral
45.
go back to reference Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med. 2008;205:2065–74.CrossRefPubMedPubMedCentral Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med. 2008;205:2065–74.CrossRefPubMedPubMedCentral
46.
go back to reference Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood. 2009;114:2367–74.CrossRefPubMed Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood. 2009;114:2367–74.CrossRefPubMed
Metadata
Title
Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions
Authors
Yasunori Matsunari
Mitsuhiko Sugimoto
Masaaki Doi
Hideto Matsui
Masahiko Kawaguchi
Publication date
01-12-2016
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 6/2016
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2086-z

Other articles of this Issue 6/2016

International Journal of Hematology 6/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine